SK pharmteco to Ensure Supply of Ferring Pharmaceuticals Gene Therapy
SK pharmteco, a CDMO, will manufacture, test, and release Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy from Ferring Pharmaceuticals for treating bladder cancer.
https://www.pharmtech.com/view..../sk-pharmteco-to-ens
Discover the world at Altruu, The Discovery Engine